Abstract | BACKGROUND: CASE REPORTS: Case 1: a 72-year-old woman with breast carcinoma relapsing after surgery, chemotherapy, hormone therapy, and without treatment for 6 months, was admitted for an acute erythematous slightly squamous and photo-distributed eruption. On clinical examination, she was found to be presenting polyadenopathy and pleural effusion. Case 2: a 46-year-old woman with a history of breast carcinoma was admitted for an erythematopapular, annular and photo-distributed eruption occurring after a second breast cancer relapse and five months after initiation of docetaxel. A new line of chemotherapy initially resulted in regression of the lesions, and progression of the breast cancer was associated with cutaneous relapse. DISCUSSION:
|
Authors | A Gantzer, S Regnier, A Cosnes, N Ortonne, P Wolkenstein, M Bagot, T-A Duong |
Journal | Annales de dermatologie et de venereologie
(Ann Dermatol Venereol)
Vol. 138
Issue 5
Pg. 409-17
(May 2011)
ISSN: 0151-9638 [Print] France |
Vernacular Title | Lupus cutané subaigu et cancer: deux cas et revue de la littérature. |
PMID | 21570567
(Publication Type: Case Reports, Journal Article, Review)
|
Copyright | Copyright © 2011 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Antibodies, Antinuclear
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Hormonal
- Autoantigens
- Ribonucleoproteins
- SS-A antibodies
- SS-A antigen
- Taxoids
- Tamoxifen
- Docetaxel
- Bevacizumab
- Epirubicin
- Cyclophosphamide
- Trastuzumab
- Paclitaxel
- Fluorouracil
|
Topics |
- Adenocarcinoma
(complications, drug therapy, radiotherapy, surgery)
- Aged
- Antibodies, Antinuclear
(blood)
- Antibodies, Monoclonal
(administration & dosage)
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Hormonal
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Autoantigens
(immunology)
- Bevacizumab
- Breast Neoplasms
(complications, drug therapy, radiotherapy, surgery)
- Combined Modality Therapy
- Cyclophosphamide
(administration & dosage)
- Docetaxel
- Epirubicin
(administration & dosage)
- Female
- Fluorouracil
(administration & dosage)
- Humans
- Lupus Erythematosus, Cutaneous
(chemically induced, diagnosis, etiology, immunology)
- Mastectomy
(methods)
- Middle Aged
- Paclitaxel
(administration & dosage)
- Paraneoplastic Syndromes
(chemically induced, diagnosis, etiology, immunology)
- Ribonucleoproteins
(immunology)
- Salvage Therapy
- Tamoxifen
(therapeutic use)
- Taxoids
(administration & dosage, adverse effects)
- Trastuzumab
|